Journal article
The Tissue-Selective Estrogen Complex: A Review of Current Evidence
Abstract
The tissue-selective estrogen complex (TSEC) has recently entered the market for the treatment of postmenopausal osteoporosis, and is particularly targeted to women with significant vasomotor symptoms. This review appraises the evidence behind the only approved TSEC to-date, a combination of bazedoxifene and conjugated estrogens, with regards to its efficacy and relevant safety concerns. The majority of evidence that has led to its approval is …
Authors
Pazhekattu R; Lau AN; Adachi JD
Journal
Rheumatology and Therapy, Vol. 2, No. 1, pp. 47–58
Publisher
Springer Nature
Publication Date
6 2015
DOI
10.1007/s40744-015-0013-z
ISSN
2198-6576